Related Experiment Video
Updated: Mar 6, 2026
10:44
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
13.9K
A Brighter Side to Thalidomide: Its Potential Use in Immunological Disorders.
David Millrine1, Tadamitsu Kishimoto2
1Cardiff Institute of Infection and Immunity, Cardiff University School of Medicine, Cardiff University, Cardiff, UK.
Trends in Molecular Medicine
|March 14, 2017
Summary
Thalidomide derivatives, known as immunomodulatory drugs (IMiDs), offer therapeutic benefits for cancers and autoimmune diseases. Recent discoveries illuminate their molecular mechanisms, paving the way for expanded clinical applications.
Area of Science:
- Immunology
- Pharmacology
- Oncology
Background:
- Immunomodulatory drugs (IMiDs), including thalidomide derivatives, possess sedative, teratogenic, anti-angiogenic, and anti-inflammatory properties.
- IMiDs are clinically utilized for treating multiple myeloma, myelodysplastic syndrome (MDS), and inflammatory conditions like Hansen's disease.
- Emerging evidence suggests potential applications in autoimmune disorders such as systemic lupus erythematosus (SLE) and inflammatory bowel disease (IBD).
Purpose of the Study:
- To review recent structural and experimental findings that elucidate the molecular mechanisms of IMiD activity.
- To assess the relevance of these discoveries for IMiD therapy in immunological disorders.
- To discuss future research directions for maximizing the clinical potential of IMiDs.
Main Methods:
- Review of recent scientific literature on thalidomide derivatives and their mechanisms of action.
- Analysis of structural and experimental data related to IMiD activity.
- Synthesis of findings to connect molecular understanding with clinical applications.
Main Results:
- Recent research has significantly advanced the understanding of IMiD molecular underpinnings.
- These advancements provide a foundation for novel therapeutic strategies in immunology and oncology.
- The anti-inflammatory and immunomodulatory effects are directly linked to specific molecular interactions.
Conclusions:
- A deeper molecular understanding of IMiDs is revolutionizing their therapeutic applications.
- IMiDs hold significant promise for treating a range of immunological and neoplastic diseases.
- Further research is crucial to fully harness the clinical potential of these versatile compounds.
Related Concept Videos
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
618
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
618
01:07Teratogenicity
4.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
01:25Immunodeficiency Diseases
2.7K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
2.7K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
670
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
670
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
584
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
584
01:29Therapeutic Drug Monitoring: Affecting Factors
300
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
300